Detalhe da pesquisa
1.
Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney Disease.
J Neuropsychiatry Clin Neurosci
; 30(4): 310-317, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045680
2.
Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes.
Circ J
; 80(3): 722-30, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26841804
3.
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Nephrol Dial Transplant
; 29(7): 1275-84, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24009287
4.
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
Kidney Int
; 82(12): 1297-303, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895515
5.
The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease.
PLoS One
; 10(7): e0131707, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26181592
6.
Uremic toxicity and sclerostin in chronic kidney disease patients.
Nephrol Ther
; 10(6): 463-70, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070604
7.
Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?
PLoS One
; 8(6): e67168, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826225
8.
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.
Clin Kidney J
; 6(1): 63-70, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27818752
9.
Association between free light chain levels, and disease progression and mortality in chronic kidney disease.
Toxins (Basel)
; 5(11): 2058-73, 2013 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24217396
10.
Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease.
Int J Artif Organs
; 35(11): 959-68, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065877